APUS Earnings Apimeds Pharmaceuticals US, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–10 of 10
| Q1 2026 | 2026-03-31 | -2.26 | 2026-05-26 | 10-Q |
| FY 2025 | 2025-12-31 | -0.55 | 2026-05-04 | 10-K |
| Q3 2025 | 2025-09-30 | -0.47 | 2025-11-12 | 10-Q |
| Q2 2025 | 2025-06-30 | -0.33 | 2025-08-19 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.05 | 2026-05-26 | 10-Q |
| FY 2025 | 2024-12-31 | -0.18 | 2026-05-04 | 10-K |
| Q3 2025 | 2024-09-30 | -0.14 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.09 | 2025-08-19 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.04 | 2025-05-20 | 10-Q |
| FY 2024 | 2023-12-31 | -0.17 | 2025-04-15 | 10-K |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.